Use access key #2 to skip to page content.
  • S&P 500: 1,145.30
  • Change: 0.43%
$6.12 +0.09 (+1.49%)
3/10/2010 3:40:51 PM

ZymoGenetics, Inc. (NASDAQ:ZGEN)

CAPS Rating:
3 out of 5

The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ZGEN

Add Stock to Watchlist

What the Community Thinks

Total Members

129 Outperforms
29 Underperforms
 

All-Stars

49 Outperforms
9 Underperforms
 

Wall Street

7 Outperforms
3 Underperforms
 

Members bullish on ZGEN are also bullish on:

Members bearish on ZGEN are also bearish on:

Ticker Tags

No Tags
Suggest a tag

ZymoGenetics, Inc. At A Glance

Current Price: $6.12
Last Trade Time: 3/10/2010 3:40 PM
Open: $6.01
Previous Close: $6.03
Daily Range: $5.96 - $6.13
52-Week Range: $3.12 - $7.31
Volume: 103,857
Market Cap: $523.12M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

ZGEN VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

ZymoGenetics, Inc. (ZGEN)

Avatar morningstarboy (92.16) Submitted: 2/21/08 1:02 PM

As of close of business on 2/20/08, this was a 5-star Morningstar stock trading at less than half of its Morningstar fair value.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

ZymoGenetics, Inc. (ZGEN)

Avatar glennwhiteside (61.87) Submitted: 12/15/08 12:21 PM

Sales of Recothrom have been miserable -- the company is expecting only $7 million this year and that was probably the low hanging fruit. CEO Bruce "Jawbone" Carter has been unable to convince Wall Street that ZGEN is turning the corner and now he's retiring. Hospitals are looking to cut costs anyw...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 23 :   1 2 3 4 5 Next »

Recs

0

 (ZGEN)

Avatar cashsage (30.11) Submitted: 2/04/10 3:50 PM : Underperform Start Price: $5.11 ZGEN Score: -11.72

ZGEN has a too high valuation compared to its sales potential. It is also loss making at least until 2011.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ZGEN)

Avatar TheBigLab (52.61) Submitted: 7/22/09 6:52 PM : Outperform Start Price: $5.15 ZGEN Score: -2.13

Will be bought or be a one hit wonder.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ZGEN)

Avatar andrelon (< 20) Submitted: 7/20/09 9:02 AM : Outperform Start Price: $4.89 ZGEN Score: 3.30

Big Pharma (BMY) made a deal
to buy 50% rights for the new drug expected to
be ready for FDA approval early next year.

They will pay ZGEN one billion dollars

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ZGEN)

Avatar Tyrone85 (98.80) Submitted: 5/20/09 12:00 AM : Outperform Start Price: $4.45 ZGEN Score: 10.98

$4.43 heah to $10.00 or more

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ZGEN)

Avatar Flightequipt (96.56) Submitted: 3/11/09 6:39 PM : Outperform Start Price: $3.22 ZGEN Score: 28.65

Great Hep C drug- How do you spell ROACH?

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 23 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 10 of 10  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart PriceStock
Gain
Index
Gain
ScorePitch
TrackOppenheimer 84.73 10/27/09 Underperform NS $5.38 +13.38%+6.04%-7.34
TrackWedbush 84.20 03/20/09 Outperform NS $3.97 +53.65%+49.53%+4.12
TrackBreanMurray 89.44 10/28/08 Underperform NS $3.56 +71.35%+34.78%-36.57
TrackEveillard 93.71 03/31/08 Outperform NS $9.80 -37.76%-9.84%-27.92 Toggle the visibility of 60-Second Pitch and replies
TrackSoros 87.03 09/30/07 Outperform NS $13.05 -53.26%-21.21%-32.05 Toggle the visibility of 60-Second Pitch and replies
TrackStanfordRes 84.74 08/02/07 Outperform NS $12.00 -49.17%-17.70%-31.46
TrackBearStearns 88.50 03/09/07 Outperform NS $15.86 -61.54%-13.82%-47.72
TrackAGEdwards 93.60 01/04/07 Outperform NS $15.32 -60.18%-13.77%-46.42
TrackJimCramer < 20 11/09/06 Underperform 3W $15.71 -61.17%-11.94%+49.23
TrackInfiniumSec None 08/17/06 Outperform NS $19.00 -67.89%-4.91%-62.99

Results 1 - 10 of 10  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD12 359ms